Drugs / NAFT-600
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01289015 | Feb → Nov 2011 | tinea pedis | Merz North America, Inc. | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NAFT-600 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01289015 ↗ |
| Known as | naftin | “NAFT-600 ( naftin 2 % gel )” NCT01289015 ↗ |
| Route | Topical | “Topical; applied once daily for two weeks” NCT01289015 ↗ |